Physician profile
Robert Alan Kaplan
NPI 1255309472
$1,444.15
in general payments reported to CMS, 2019-2025
18 companies · $27.73 in 2025
The $27.73 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $190 · 2021: $372 · 2022: $284 · 2023: $75.46 · 2024: $124 · 2025: $27.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $227.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $366.84 | 2019-2025 | Bexsero |
| Sanofi Pasteur INC. | $204.42 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $133.75 | 2020-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Adlon Therapeutics L.P. | $124.21 | 2019-2021 | |
| Abbvie INC. | $119.99 | 2019 | |
| Pfizer INC. | $69.51 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $64.06 | 2019 | |
| Nuvasive, INC. | $56.00 | 2021 | |
| Baxter Healthcare | $55.41 | 2022 | |
| Welch Allyn | $48.49 | 2021 | |
| Abbott Laboratories | $44.57 | 2019 | |
| Neos Therapeutics, LP | $43.89 | 2020 | |
| Tris Pharma INC | $33.13 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.90 | 2019 | |
| Kaleo, INC. | $17.66 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seqirus USA INC | $15.28 | 2021 | |
| Cranial Technologies, INC | $15.00 | 2023 | Doc Band |
| Verrica Pharmaceuticals INC. | $13.04 | 2023 | Ycanth |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kaplan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.